Clinical Trial Update: Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the antiviral activity of pegylated interferon alfa-2a in chronic HIV-1 infection. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Peg-IFN-Alpha-2A (Pegasys) (pegylated interferon alfa-2a)

Snippet

Sponsor: The Wistar Institute | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-02-10